All Stories

  1. A wearable respiratory dataset spanning clinical and asymptomatic adults
  2. Effects of hyperoxia on pulmonary inflammation and organ injury in a human in vivo model (HIPI): a randomised controlled trial
  3. Low-cost colourimetric biosensing using laser-patterned cellophane-based fluidic devices
  4. Methods for Evaluating Models, Tests And Biomarkers (MEMTAB): Abstracts from the 7th International Conference, MEMTAB 2025
  5. Outcome and Oxygenation Response to Airway Pressure Release Ventilation (APRV) Used as a Rescue Strategy for Severe Hypoxemic Respiratory Failure—An Observational Study
  6. Surfactant nebulization in severe COVID-19: Tracheal aspirate phospholipid turnover and metabolism
  7. Systemic corticosteroids for severe community-acquired pneumonia: a narrative review of mechanisms and critical appraisal of recent trials in ICU
  8. Effects of Sample Deposition Medium and Drying on Spectroscopic Quantification of Lipid Biomarkers in Respiratory Distress Syndrome
  9. Fabrication of cellophane-based microfluidic devices using laser direct-write approach
  10. Identification and antimicrobial susceptibility testing of MRSA using miniaturized fluidic wells laser-patterned on transparent substrate
  11. Low-cost colourimetric biosensing using laser-patterned cellophane-based fluidic devices
  12. Expression of cell-surface activation markers on human CD15+ cells after selected non esterified fatty acid supplementations
  13. The role of corticosteroids in the management of non-COVID-19 severe community-acquired pneumonia in the intensive care unit: A narrative review
  14. Hyperoxia and Surfactant Dysfunction in Critical Illness: Insights and Future Therapeutic Prospects
  15. Severe viral infections requiring intensive care unit admissions- aetiology, co-infections, respiratory interventions and outcomes
  16. Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients
  17. Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients
  18. Cost-Effectiveness of α2 Agonists for Intravenous Sedation in Patients With Critical Illness
  19. Improving physical function with physiotherapy assistants following intensive care unit admission (EMPRESS): A randomised controlled feasibility study
  20. Evaluation of the physiological variables and scoring systems at intensive care discharge as predictors of clinical deterioration and readmission: a single-centre retrospective study
  21. Corticosteroids for the management of severe community-acquired pneumonia: A UK-wide survey
  22. The tear production of tecovirimat in a single hospitalized mpox patient: a pharmacokinetic analysis
  23. Lung Ultrasound in Critical Care: A Narrative Review
  24. Physiology and pathophysiology of mucus and mucolytic use in critically ill patients
  25. Pre-Hospital Critical Care for Out-of-Hospital Cardiac Arrests with Return of Spontaneous Circulation: A Retrospective Observational Study
  26. Immunoglobulin unresponsive Guillain-Barré syndrome: rinse or repeat? A systematic review
  27. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study
  28. Exploring Antibacterial Usage and Pathogen Surveillance over Five Years in a Tertiary Referral Teaching Hospital Adult General Intensive Care Unit (ICU)
  29. Management of adult mechanically ventilated patients: A UK-wide survey
  30. Best Abstracts
  31. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study
  32. Surfactant Phospholipid Kinetics in Ventilated Children after Therapeutic Surfactant Supplementation
  33. Characteristics, Management, and Outcomes of Acute Life-Threatening Asthma in Adult Intensive Care
  34. Intensive Care Management of Severe Hyponatraemia—An Observational Study
  35. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study
  36. Towards quantifying biomarkers for respiratory distress in preterm infants: Machine learning on mid infrared spectroscopy of lipid mixtures
  37. Oxidative stress, redox status and surfactant metabolism in mechanically ventilated patients receiving different approaches to oxygen therapy (MecROX): An observational study protocol for mechanistic evaluation
  38. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study
  39. Particles in Exhaled Air (PExA): Clinical Uses and Future Implications
  40. Oxidative stress, redox status and surfactant metabolism in mechanically ventilated patients receiving different approaches to oxygen therapy (MecROX): An observational study protocol for mechanistic evaluation
  41. Particles in Exhaled Air (PExA): Clinical Uses and Future Implications
  42. Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
  43. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
  44. In Vivo Cellular Phosphatidylcholine Kinetics of CD15+ Leucocytes and CD3+ T-Lymphocytes in Adults with Acute Respiratory Distress Syndrome
  45. Management of Acute Life-Threatening Asthma Exacerbations in the Intensive Care Unit
  46. Characterization of Binary Liposome with Raman Spectroscopy for Targeted Nanomedicine
  47. Non-Invasive Ventilation for Community-Acquired Pneumonia: Outcomes and Predictors of Failure from an ICU Cohort
  48. Organisation and delivery of a dedicated multidisciplinary prone ventilation team in the intensive care unit: Strategies and lessons from COVID-19
  49. Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19
  50. Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
  51. Simvastatin in Critically Ill Patients with Covid-19
  52. A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)
  53. Severe Parainfluenza Viral Infection—A Retrospective Study of Adult Intensive Care Patients
  54. Intravenous Vitamin C for Patients Hospitalized With COVID-19
  55. Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia
  56. International Pediatric COVID-19 Severity Over the Course of the Pandemic
  57. Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions
  58. Predictors of mortality for major trauma patients in intensive care: A retrospective cohort study
  59. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial
  60. Prone Positioning in Mechanically Ventilated COVID-19 Patients: Timing of Initiation and Outcomes
  61. Provision of Microbiology, Infection Services and Antimicrobial Stewardship in Intensive Care: A Survey across the Critical Care Networks in England and Wales
  62. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
  63. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
  64. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
  65. Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
  66. The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery (PREVENTT) trial
  67. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial
  68. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
  69. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19
  70. S44 Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID trial): 1 year follow up for safety and pulmonary dysfunction
  71. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study
  72. Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the “obesity paradox” phenomenon
  73. Aspergillus in COVID-19 intensive care unit; what is lurking above your head?
  74. Caring for COVID‐19 patients through a pandemic in the intensive care setting: A narrative review
  75. Antimicrobial stewardship programmes focused on de-escalation: a narrative review of efficacy and risks
  76. Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study
  77. Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission
  78. Plasma and Airway Levels of Surfactant Protein D Degradation Reflect Progression of ARDS in Ventilated Patients with SARS-CoV-2
  79. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cell Administration (REALIST-COVID) Phase 2 Randomised Controlled Trial
  80. Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study
  81. Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
  82. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19
  83. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
  84. Improving physical function of patients following intensive care unit admission (EMPRESS): protocol of a randomised controlled feasibility trial
  85. Severe COVID‐19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses
  86. Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial
  87. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
  88. Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital
  89. Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics
  90. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
  91. Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
  92. Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
  93. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
  94. A prenylated dsRNA sensor protects against severe COVID-19
  95. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study
  96. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study
  97. Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19?
  98. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
  99. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
  100. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
  101. Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit
  102. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
  103. Mapping the human genetic architecture of COVID-19
  104. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
  105. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
  106. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
  107. Severe COVID-19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses
  108. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
  109. Methodology to detect oxidised phospholipids and their relevance in disease
  110. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19
  111. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
  112. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
  113. Intensive care physicians’ perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey
  114. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study
  115. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
  116. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
  117. Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients
  118. Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study
  119. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study
  120. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
  121. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
  122. Goal-directed haemodynamic therapy (GDHT) in surgical patients: systematic review and meta-analysis of the impact of GDHT on post-operative pulmonary complications
  123. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
  124. In-hospital cardiac arrest audit: An audit reviewing outcomes
  125. Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre
  126. Prediction of mortality in critically-ill elderly trauma patients: a single centre retrospective observational study and comparison of the performance of trauma scores
  127. Inflammatory phenotyping predicts clinical outcome in COVID-19
  128. Recurrent Pneumothorax in a Critically Ill Ventilated COVID-19 Patient
  129. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
  130. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit
  131. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
  132. Conscious prone positioning during non-invasive ventilation in COVID-19 patients: experience from a single centre
  133. Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID‐19 pneumonia
  134. Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study
  135. Clinical characteristics and outcome of critically ill COVID-19 patients with Acute Kidney Injury: A single centre cohort study
  136. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
  137. P196 Outcome of COPD patients started on inpatient domiciliary NIV following an acute admission with hypercapnic respiratory failure
  138. Immunonutrition for Adults With ARDS: Results From a Cochrane Systematic Review and Meta-Analysis
  139. Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome
  140. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults
  141. P200 A review of domiciliary non-invasive ventilation for patients with motor neurone disease (MND) in a regional centre
  142. P204 A retrospective study of home non-invasive ventilation for patients with severe COPD in a regional centre
  143. P208 The use of non-invasive ventilation in patients with community acquired pneumonia admitted to the intensive care unit
  144. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review
  145. Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome
  146. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures
  147. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial
  148. Abstracts
  149. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults
  150. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome
  151. Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians
  152. Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers
  153. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review † †This review is an abridged version of a Cochrane Review previously published in the Cochrane Database of Systematic Review...
  154. Proceedings of the Anaesthetic Research Society Meeting
  155. Perioperative buffered versus non-buffered fluid administration for surgery in adults
  156. S18 Bronchoalveolar Lavage, Tracheal Wash and Induced Sputum Surfactant Phospholipid Kinetics from Healthy Volunteers
  157. S58 Surfactant Phospholipid Kinetics in Patients with Acute Respiratory Distress Syndrome (ARDS)
  158. S65 Raised CK Levels in Severe Asthmatics Admitted to the Critical Care Unit- A Retrospective Cohort Analysis
  159. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery
  160. ESICM 2012 MONDAY SESSIONS 15 October, 2012
  161. Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
  162. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
  163. Acute respiratory distress syndrome and acute lung injury
  164. Unusual case of unilateral whiteout on chest radiograph with evidence of previous pulmonary tuberculosis exposure
  165. Nocturia, enuresis and snoring: an unusual combination in an adult?
  166. Multiple pulmonary micronodules in a patient with Crohn's disease
  167. Outcome Of A Cohort Of Older Population With COPD, Admitted With Hypercapnaeic Respiratory Failure And Acidosis
  168. Observed Other Primary Malignancies In Patients With Lung Cancer
  169. Summer-type relapsing fever (hypersensitivity pneumonitis) secondary to Cladosporium herbarum in the domestic environment
  170. Developmental Regulation of p66ShcIs Altered by Bronchopulmonary Dysplasia in Baboons and Humans
  171. Are ColonialHaemophilus influenzaeResponsible for Exacerbations of Chronic Obstructive Pulmonary Disease After All?